earlier than other factors.
The RCOG Guideline on Prevention and Management of PPH recommends that coagulation testing should be repeated at intervals "such as every thirty minutes" during continued bleeding (Green Top Guideline No. 52, 2016 : page e124) but it adds that although laboratorybased tests are widely available and have good quality control, "turnaround times are often too slow to be clinically useful".
Point-of-care (POC) coagulation testing, then, seems the next logical step. Tests such as rotational thromboelastometry (ROTEM) give rapid results and are recommended by the Obstetric Anaesthetists Association and the Association of Anaesthetists of Great Britain and Ireland. The
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This article is protected by copyright. All rights reserved RCOG Guideline mentions the anaesthetists' recommendation but also states: "NICE has concluded that there is insufficient evidence to recommend the routine adoption of viscoelastometric POC testing in the management of PPH".
Part of the problem is that most studies of POC coagulation testing have come from cardiovascular surgery and trauma management. Pregnancy, however, causes physiological changes in coagulation factors. Plasma fibrinogen concentration is increased at term and coagulation factors, including fibrinogen, are altered by labour itself. Reference ranges for POC tests therefore need to be established for women in labour, in studies of adequate size -which, according to the International Federation of Clinical Chemistry (IFCC), means at least 120 subjects.
This study by Lee et al. (BJOG 2020 xxx) from Brisbane includes 121 healthy women in labour and is the first such study to meet the IFCC criterion. It provides a more detailed picture than previous studies of ROTEM in pregnancy. Nevertheless, the authors point out that their results are not generalisable to women at earlier gestational ages or postpartum. Further evaluation of ROTEM, particularly in prolonged labour, will be needed.
Meanwhile reports have begun to appear of the use of POC coagulation testing in obstetric practice. In Liverpool, for example, a ROTEM-guided algorithm has been used for over four years in the treatment of obstetric haemorrhage. McNamara et al. (Anaesthesia 2019; 74: 984-91) found that coagulopathy cannot be predicted solely by blood loss but can be severe, and individualised treatment is required. In Cardiff, Collins et al. (Int J Obstet Anesth 2019; 37:106-17) found that, even in severe PPH, deficiencies of coagulation factors other than fibrinogen are uncommon and ROTEM monitoring can inform safely withholding FFP in most women. An ongoing quality improvement programme has been designed for all maternity units in Wales.
The evidence for POC coagulation testing is mounting but all the reports -until nowhave appeared in journals of laboratory science or anaesthetics. Management of severe PPH requires a multispecialty team including obstetricians, anaesthetists, intensivists and haematologists, and obstetricians should play their part in gathering further evidence.
